Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Go back to Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation| AbbVie (NYSE: ABBV) | Delayed: 264.96 +3.13 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $261.83 | 52 Week High | $68.12 | |||
| Open | $260.70 | 52 Week Low | $50.71 | |||
| Day High | $266.84 | P/E | 57.48 | |||
| Day Low | $260.10 | EPS | $4.61 | |||
| Volume | 5,157,114 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.78 +2.43 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.76 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 722,348 | |||||
